Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Breast Cancer Stem Cells. | Int J Biol Sci | 2023 | 36632469 | PubTator, text mining | PubMed |
| Development of Multilayer Transducer and Omnidirectional Reflection Model for Active Reflection Control. | Sensors (Basel) | 2023 | 36617118 | PubTator, text mining | PubMed |
| Mutation-associated transcripts reconstruct the prognostic features of oral tongue squamous cell carcinoma. | Int J Oral Sci | 2023 | 36593250 | PubTator, text mining | PubMed |
| Silencing of RhoC induces macrophage M1 polarization to inhibit migration and invasion in colon cancer via regulating the PTEN/FOXO1 pathway. | Int J Exp Pathol | 2023 | 36576072 | PubTator, text mining | PubMed |
| ARHGAP17 regulates the spatiotemporal activity of Cdc42 at invadopodia. | J Cell Biol | 2023 | 36571786 | PubTator, text mining | PubMed |
| Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor. | Blood | 2023 | 36564030 | PubTator, text mining | PubMed |
| Identification of an inhibitory domain in GTPase-activating protein p190RhoGAP responsible for masking its functional GAP domain. | J Biol Chem | 2023 | 36516886 | PubTator, text mining | PubMed |
| LncRNA ZFAS1 contributes to osteosarcoma progression via miR-520b and miR-520e-mediated inhibition of RHOC signaling. | Clinics (Sao Paulo) | 2023 | 36473367 | PubTator, text mining | PubMed |
| Interactive mechanisms between caveolin-1 and actin filaments or vimentin intermediate filaments instruct cell mechanosensing and migration. | J Mol Cell Biol | 2023 | 36472547 | PubTator, text mining | PubMed |
| High-Throughput Cellular Heterogeneity Analysis in Cell Migration at the Single-Cell Level. | Small | 2023 | 36449634 | PubTator, text mining | PubMed |
| Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles. | Mol Cell Proteomics | 2023 | 36435334 | PubTator, text mining | PubMed |
| Research progress on the circRNA‑mediated regulation of tumor angiogenesis through ceRNA mechanisms (Review). | Oncol Rep | 2023 | 36416347 | PubTator, text mining | PubMed |
| JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States. | Cancer Res | 2023 | 36409824 | PubTator, text mining | PubMed |
| Plasticity of cancer invasion and energy metabolism. | Trends Cell Biol | 2023 | 36328835 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| MicroRNAs: protective regulators for neuron growth and development. | Neural Regen Res | 2023 | 36204829 | PubTator, text mining | PubMed |
| Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance. | Korean J Clin Oncol | 2022 | 36945332 | PubTator, text mining | PubMed |
| LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance. | Front Genet | 2022 | 36726721 | PubTator, text mining | PubMed |
| Amoeboid migration in health and disease: Immune responses versus cancer dissemination. | Front Cell Dev Biol | 2022 | 36699013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=12